RFK Jr. urges FDA to overlook unproven peptide drugs despite safety concerns

This report highlights that RFK Jr. has proposed the FDA disregard safety and efficacy standards for certain popular peptide drugs. FDA scientists have stated that none of these drugs have been proven safe or effective, raising concerns about the proposal's implications for public health.

Originally published by arstechnica